Eli Lilly

  • Dividend Trouble

    By Alexei Bayer  |  November 23, 2011

    In the third quarter, an unusual situation arose in U.S. financial markets: dividend yield on stocks surpassed the interest rate on the 10-year Treasury bond. While some technical analysts saw this as a strong “buy” signal, and the market did subsequently rally, the real explanation is probably far less favorable...

  • High Hopes and Altered Genes

    By Kenneth Silber  |  October 1, 2009

    Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...

  • Michael Yellen of AIM Global Health Care Fund

    By Staff Writer  |  January 31, 2003

    S&P Rank: 4 Stars Good Prognoses for Drug Stocks